Mark Shearman - Jun 15, 2022 Form 4 Insider Report for Editas Medicine, Inc. (EDIT)

Role
EVP, CHIEF SCIENTIFIC OFFICER
Signature
/s/ Mark S. Shearman
Stock symbol
EDIT
Transactions as of
Jun 15, 2022
Transactions value $
-$51,745
Form type
4
Date filed
6/16/2022, 04:15 PM
Previous filing
Feb 11, 2022
Next filing
Feb 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EDIT Common Stock Sale -$51.7K -5.15K -7% $10.06 68.3K Jun 15, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on April 19, 2021 and represents the sale of shares necessary to meet tax withholding obligations as a result of vesting in restricted stock units and in performance stock units on June 14, 2022. The sale does not represent a discretionary trade by the Reporting Person.